Markus Falk
8PUBLICATIONS
21CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Aug 09, 2024
Intracranial response to capmatinib after progression on crizotinib in a patient with MET exon 14 skipping non-small cell lung cancer-a case report.Balázs Jóri, Otto Bundschuh, Markus Falk
|Oct 27, 2023
Fluctuation of Acquired Resistance Mutations and Re-Challenge with EGFR TKI in Metastatic NSCLC: A Case Report.Markus Falk, Stefanie Schatz, Fabian P M Reich
|Oct 27, 2023
The Combined Therapy of Cabozantinib, Crizotinib, and Osimertinib in a Lung Cancer Patient with Acquired MET Amplification and Resistance Mutations.Balázs Jóri, Christine Vössing, Judith Pirngruber
|Jul 14, 2023
Development of the NOGGO GIS v1 Assay, a Comprehensive Hybrid-Capture-Based NGS Assay for Therapeutic Stratification of Homologous Repair Deficiency Driven Tumors and Clinical Validation.Eva-Maria Willing, Claudia Vollbrecht, Christine Vössing
|Feb 24, 2023
Response of an HER2-Mutated NSCLC Patient to Trastuzumab Deruxtecan and Monitoring of Plasma ctDNA Levels by Liquid Biopsy.Markus Falk, Eva Willing, Stefanie Schmidt
|Sep 22, 2022
Acquired G2032R Resistance Mutation in ROS1 to Lorlatinib Therapy Detected with Liquid Biopsy.Balázs Jóri, Markus Falk, Iris Hövel
Pageof 2
Frequent Collaborators
4 joint publications
Stefanie Schatz
4 joint publications
Balázs Jóri
2 joint publications
Wolfgang M Brueckl
2 joint publications
Eva-Maria Willing
1 joint publications
André Fehr
1 joint publications
Reinhard E Friedrich
1 joint publications
Andreas Stang
1 joint publications
Florian Oesterling
1 joint publications
Göran Stenman
1 joint publications
Thomas Löning
